Business
MedMira and Swiss Investor Andurja Complete Previously Announced Funding as a $1 Million Equity Investment
MedMira and Swiss Investor Andurja Complete Previously Announced Funding as a $1 Million Equity I...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\n Dec. 1, 2010 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nHALIFAX, Dec. 1 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\n NASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology\n and solutions, today announced that it has received TSX Venture\n Exchange approval to complete the $1 million equity investment from\n Andurja AG (Andurja), a Swiss investment company based in Lucerne,\n Switzerland.  This funding has transitioned from the CDN$1 million\n convertible debenture investment announced on October 30, 2010 to an\n equity investment in MedMira. Andurja is currently the controlling\n shareholder of MedMira. \n\n\nUnder the terms of the deal Andurja acquired 20,000,000 equity units at\n $0.05 per unit. Each equity unit consists of one common share and one\n common share purchase warrant. Each full warrant entitles Andurja to\n purchase one common share of MedMira at $0.10 per share for a four year\n period. The common shares and the warrants are subject to a four month\n hold period that expires four months from the day of share issuance. \n With the completion of this transaction, Andurja now owns 27.1% of\n undiluted common shares of MedMira.\n\n\nAbout Andurja AG/Vitest AG\nAndurja AG is a holding company of Vitest AG. Vitest AG is a privately\n held company based in Wollerau, Switzerland (www.vitest.ch) with a corporate subsidiary in Germany (Vitest GmbH) and South Africa\n (Vitest Southern Africa Ply). Vite...